Skip to main content
Skip to content
Case File
kaggle-ho-024844House Oversight

Cowen estimates $2.4 bn CBD nutraceutical market growth post‑2018 Farm Bill

Cowen estimates $2.4 bn CBD nutraceutical market growth post‑2018 Farm Bill The passage provides only market size projections for CBD nutraceuticals with no mention of specific individuals, companies, financial transactions, or potential misconduct. It lacks actionable leads for investigative work and involves no high‑profile actors or sensitive controversy. Key insights: Projects $2.4 bn in U.S. CBD nutraceutical sales over the next two years.; Assumes CBD could capture ~30% of the broader herbal supplement market by 2020.; Notes uncertainty tied to retail adoption after the 2018 Farm Bill.

Date
Unknown
Source
House Oversight
Reference
kaggle-ho-024844
Pages
1
Persons
0
Integrity
No Hash Available

Summary

Cowen estimates $2.4 bn CBD nutraceutical market growth post‑2018 Farm Bill The passage provides only market size projections for CBD nutraceuticals with no mention of specific individuals, companies, financial transactions, or potential misconduct. It lacks actionable leads for investigative work and involves no high‑profile actors or sensitive controversy. Key insights: Projects $2.4 bn in U.S. CBD nutraceutical sales over the next two years.; Assumes CBD could capture ~30% of the broader herbal supplement market by 2020.; Notes uncertainty tied to retail adoption after the 2018 Farm Bill.

Tags

kagglehouse-oversightcbdnutraceuticalsmarket-forecastfarm-billretail-adoption
0Share
PostReddit
Review This Document

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.